Prestige Consumer Healthcare
240 hedge funds and large institutions have $2.93B invested in Prestige Consumer Healthcare in 2017 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 91 increasing their positions, 88 reducing their positions, and 27 closing their positions.
6,707% more call options, than puts
Call options by funds: $4.56M | Put options by funds: $67K
33% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 27
8% more capital invested
Capital invested by funds: $2.71B → $2.93B (+$220M)
3% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 88
1% more ownership
Funds ownership: 98.56% → 99.55% (+1%)
1% more funds holding
Funds holding: 238 → 240 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$381M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.5M |
| 3 |
MRCP
Manor Road Capital Partners
New York
|
+$28.7M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$25.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$32M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$18.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$14.3M |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$12M |
| 5 |
Bank of New York Mellon
New York
|
-$11.5M |
PBH Hedge Fund Activity: Q1 2017 in Review
240 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2017, worth a combined $2.93B — up 8.1% from $2.71B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new PBH positions and 27 closed out — a net gain of 9 holders — while 91 added to existing stakes and 88 trimmed.
The largest buyer was BlackRock, adding an estimated $381M. The largest seller was Dimensional Fund Advisors, cutting an estimated $32M.
- 240 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2017, up from 238 in Q4 2016.
- Funds reported $2.93B of Prestige Consumer Healthcare stock for Q1 2017, up 8.1% quarter-over-quarter.
- 36 funds opened new Prestige Consumer Healthcare positions in Q1 2017 and 27 closed out, a net change of +9 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2017 was BlackRock, an estimated $381M added.
- The largest Prestige Consumer Healthcare seller in Q1 2017 was Dimensional Fund Advisors, an estimated $32M sold.
Based on aggregated 13F filings for Q1 2017.